). Myo1p is the first example of a myosin whose cellular function does not require a catalytic motor domain revealing a novel mechanism of action for budding yeast myosin-II independent of actin binding and ATPase activity.![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2005, The American Society for Cell Biology Cytokinesis Depends on the Motor Domains of Myosin-II in Fission Yeast but Not in Budding Yeast * Departments of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520-8103 † Departments of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8103 ‡ Departments of Cell Biology, Yale University, New Haven, CT 06520-8103 Anthony Bretscher, Monitoring Editor Address correspondence to: Thomas D. Pollard (thomas.pollard/at/yale.edu). Received July 6, 2005; Revised August 19, 2005; Accepted August 25, 2005. This article has been cited by other articles in PMC.Abstract Budding yeast possesses one myosin-II, Myo1p, whereas fission yeast has two, Myo2p and Myp2p, all of which contribute to cytokinesis. We find that chimeras consisting of Myo2p or Myp2p motor domains fused to the tail of Myo1p are fully functional in supporting budding yeast cytokinesis. Remarkably, the tail alone of budding yeast Myo1p localizes to the contractile ring, supporting both its constriction and cytokinesis. In contrast, fission yeast Myo2p and Myp2p require both the catalytic head domain as well as tail domains for function, with the tails providing distinct functions (Bezanilla and Pollard, 2000 ). Myo1p is the first example of a myosin whose cellular function does not require a catalytic motor domain revealing a novel mechanism of action for budding yeast myosin-II independent of actin binding and ATPase activity.INTRODUCTION Cytokinesis, the physical separation of dividing cells, is a fundamental but poorly understood event. Formation of a cleavage furrow depends on the actin-based motor myosin-II to constrict a contractile ring of actin filaments (Mabuchi and Okuno, 1977 ). Genetic studies in budding and fission yeast (Guertin et al., 2002 ) and RNA interference experiments on animal cells (Somma et al., 2002 ; Kiger et al., 2003 ; Rogers et al., 2003 ; Echard et al., 2004 ) have identified a growing list of other genes required for cytokinesis.The heavy chain of myosin-II forms an N-terminal catalytic domain (head) and a C-terminal coiled-coil tail. The head binds actin filaments and catalyzes ATP hydrolysis. The segment of the heavy chain between the catalytic domain and the tail binds two light chains related to calmodulin: an essential light chain (ELC) and a regulatory light chain (RLC). This light chain domain forms a lever arm that amplifies the force-producing conformational changes in the head. Phosphorylation of RLCs regulates the motor activity of animal cell myosin-II (Sellers et al., 1981 ; Bresnick, 1999 ), whereas an Unc45-/Cro1p-/She4p-related (UCS) protein regulates the motor activity of fission yeast myosin-II (Lord and Pollard, 2004 ). Myosin-II tails assemble into bipolar filaments, allowing contraction of actin filaments in muscle and other cells. The tails of nonmuscle myosin-II may have additional functions. The tails of myosin-II from Dictyostelium and Acanthamoeba have a role in recruitment to the cleavage furrow (Yumura and Uyeda, 1997 ; Zang and Spudich, 1998 ; Shu et al., 1999 , 2003 ).The fission yeast, Schizosaccharomyces pombe, has two myosin-II heavy chains, both paired with ELC Cdc4p (McCollum et al., 1995 ; Motegi et al., 2000 ; Naqvi et al., 2000 ; Lord et al., 2004 ) and RLC Rlc1p (Le Goff et al., 2000 ; Naqvi et al., 2000 ; Lord and Pollard, 2004 ). Myo2p is essential for cytokinesis and viability under most conditions (Kitayama et al., 1997 ; May et al., 1997 ; Balasubramanian et al., 1998 ), but Myp2p is required only under special stressful conditions (Bezanilla et al., 1997 ; Motegi et al., 1997 ). The tails specify unique functions, including localization of Myo2p and Myp2p at the contractile ring (Naqvi et al., 1999 ; Bezanilla and Pollard, 2000 ; Bezanilla et al., 2000 ). Myo2p is “conventional” in the sense that two heavy chains form a rod-shaped, coiled-coil tail that is insoluble at low ionic strength, presumably owing to the formation of filaments (Bezanilla and Pollard, 2000 ; Lord and Pollard, 2004 ). Myo2p is the second known contractile ring protein to concentrate around the equator of dividing cells, independent of actin filaments and septins, which arrive later (Naqvi et al., 1999 ; Wu et al., 2003 ). Accumulation of Myo2p at the cell equator is dependent on dephosphorylation of a phosphoserine at the C terminus of its tail (Motegi et al., 2004 ). Compaction of Myo2p into a tight contractile ring depends on actin filaments (Motegi et al., 2000 ; Wu et al., 2003 ) and Rng3p (Wong et al., 2000 ; Lord and Pollard, 2004 ). Myp2p is “unconventional,” because the tail has a large insert between two segments of heptad repeats. This allows isolated tail polypeptides to fold back to form an antiparallel coiled-coil, indicating that Myp2p is monomeric with a single head (Bezanilla and Pollard, 2000 ). In spite of this unconventional structure, the tails are insoluble at physiological ionic strength. Myp2p joins the contractile ring 25 min after Myo2p (Wu et al., 2003 ) whereupon it acts to stabilize the contractile ring (Mulvihill and Hyams, 2003 ).Budding yeast (Saccharomyces cerevisiae) myosin-II, Myo1p, contributes to cytokinesis and primary septum formation (Watts et al., 1987 ; Bi et al., 1998 ; Lippincott and Li, 1998 ; Schmidt et al., 2002 ). In certain strain backgrounds (e.g., BF264-Du), myo1Δ cells are viable despite morphological defects at the division site and failure of cytokinesis in some cells (Bi et al., 1998 ). In other backgrounds (e.g., W303a), the severity of cytokinesis defects results in lethality (Tolliday et al., 2003 ). Mlc1p is the ELC and Mlc2p is the RLC for Myo1p (Luo et al., 2004 ). Like the Myp2p tail, the Myo1p tail is relatively long, with two distinct coiled-coil regions separated by a segment unlikely to form a coiled-coil (Bezanilla and Pollard, 2000 ). No information is available on the physical properties of the Myo1p tail. Concentration of Myo1p in the contractile ring early in the cell cycle at G1/S phase depends on the septin protein complex but not on actin filaments (Bi et al., 1998 ; Lippincott and Li, 1998 ).We investigated the functional relationships among Myo1p, Myo2p, and Myp2p by using complementation and localization experiments. Remarkably, the Myo1p tail alone fully supports localization to the contractile ring and cytokinesis of both the BF264-Du and W303a strains of budding yeast. In contrast, both the heads and tails of Myo2p and Myp2p are necessary for their function in fission yeast. Our work reports the first known case of a myosin that maintains its cellular function without a motor domain and highlights the importance of myosin-II tails in cytokinesis. MATERIALS AND METHODS Yeast Strains, Growth Conditions, Cell, and Genetic Methods Table 1 lists budding and fission yeast strains. Standard budding and fission yeast growth conditions, genetic methods, and DNA staining procedures were used (Rose et al., 1990 ; Moreno et al., 1991 ). We used two different myo1Δ strains with different genetic backgrounds: JC 1609 in the BF264-Du background, in which deletion of MYO1 is not lethal; and RLY 1236 in the W303a background, in which MYO1 is essential (Tolliday et al., 2003 ). We used the JC1609 strain for complementation experiments using haploids. Derivatives of JC 1609 (referred to as JC 1609 for simplicity) were used after thorough backcrossing with a congenic wild-type strain to eliminate the emergence of suppressors, which are known to arise in this myo1Δ haploid background (Tolliday et al., 2003 ). To test the ability of constructs to rescue in a background where MYO1 represents an essential gene, we transformed a heterozygote diploid (RLY 1236 myo1Δ:kanR/MYO1) with appropriate plasmids. Transformants were sporulated and tetrads were dissected onto YPDa plates. Segregants were further tested for geneticin resistance (kanR) on YPDa plates containing 200 mg/ml geneticin (Invitrogen, Carlsbad, CA), plasmid possession on CSM-Trp- plates, and mating type by halo assays using a- (JC 19) and α-factor (JC 65) tester strains. Budding yeast strains carrying green fluorescent protein (GFP) fusion protein plasmids were used in complementation and localization experiments after growing exponentially in CSM-Trp- medium.
Fission yeast strains carrying GFP fusion protein plasmids were selected on EMM minus leucine plates containing 5 μg/ml thiamine. Cells were used in experiments after growing exponentially in EMM minus leucine plus 5 μg/ml thiamine (repressing conditions for complementation experiments) or plus 5-50 ng/ml thiamine (semirepressing conditions for localization experiments). Truncation and GFP tagging of chromosomal myp2 was achieved using the one-step PCR and homologous integration method of Bahler et al. (1998 ). The geneticin-resistance gene (kanR) and nourseothricin-resistance gene (natR) were used to truncate myp2 at the N terminus (“headless”) and C terminus (“tailless”), respectively. The N-terminal truncation resulted in replacement of the first 849 amino acids of Myp2p with GFP, whereas the C-terminal truncation resulted in removal of the last 1255 amino acids. Oligonucleotides containing kanR or natR were integrated into chosen strains through high efficiency transformation. Integrants were subsequently selected on YE5S plates containing 100 μg/ml geneticin or 50 μg/ml clonNAT (Werner Bioreagents, Hamburg, Germany). Oligonucleotides were amplified with a High Fidelity polymerase (Roche Diagnostics, Indianapolis, IN) from pFA6a-myp2 promoter-GFP-kanMX6 or pFA6a-natMX4 accordingly. Correct integration was confirmed by diagnostic PCR of genomic DNA using oligonucleotides derived from the sequence of selective markers and the target site. The phenotype and localization of integrated Myp2p GFP fusion proteins were analyzed after exponential growth in EMM medium (20°C) and YE5S medium (30°C), respectively.GFP fusion proteins/stains were imaged in cells as described previously (Lord and Pollard, 2004 ). Images were captured with an Olympus IX71 microscope by epifluorescence illumination with a PlanApo 60× (1.4 numerical aperture) objective and recorded with an Orca-ER cooled charge-coupled device camera (Hamamatsu, Bridgewater, NJ). For spinning disk confocal microscopy, the microscope was connected to a confocal scanner (model UltraView RS; PerkinElmer Life and Analytical Sciences, Boston, MA), and the images were captured with a PlanApo 100× (1.4 numerical aperture) objective. Images were acquired and processed using MetaMorph, Utra View RS, Image J, and PhotoShop software.Plasmid Construction Table 2 lists the plasmid constructs used in this study. The fidelity of constructs was verified by automated DNA sequencing (Keck Facility, Yale University, New Haven, CT).
pPGT. An 800-base pair region upstream of the MYO1 open reading frame (ORF) (encompassing the MYO1 promoter) was amplified from budding yeast genomic DNA with 5′ KpnI-prom (GGTACCGCATAGACGATCTCTACGAC) and 3′ XhoI-prom (CTCGAGTATTGCTGTTGTTGTCCTGTC). The DNA was ligated into KpnI/XhoI linearized pRS314. A XhoI/NotI GFP fragment was liberated from p573-81X and ligated into XhoI/NotI linearized pRS314-MYO1promoter plasmid. A 1-kb terminator region immediately downstream of the MYO1 ORF was amplified from genomic DNA with 5′ NotI-SalI-term (GCGGCCGCTTTAGTCGACGACGACACGAGCGTTATATAC) and 3′ SacI-term (GAGCTCGAATTATTCCACATCCAGATCGG) and ligated into NotI/SacI linearized pRS314-MYO1promoter-GFP to yield pPGT. pGFP-myo2/-myp2. NotI/SalI myo2 and myp2 fragments were liberated from p573-81X-myo2 and p573-81X-myp2, respectively, and ligated into NotI/SalI linearized pPGT, generating pGFP-myo2 and pGFP-myp2. pGFP-MYO1/MYO1H-myo2T/-MYO1H-myp2T/-myo2H-MYO1T/-myp2H-MYO1T. We constructed chimeric myosin head-tail budding yeast constructs using a cloning strategy similar to that used to generate fission yeast myosin-II chimeras (Bezanilla and Pollard, 2000 ). As with myo2 and myp2, the conserved sequence CCTTGG (encoding amino acids ProTrp in each myosin-II) was found at the junction of the DNA regions encoding the head and tail of Myo1p (base pairs 2524-2529, aa 842-843). When constructing the 3′ head and 5′ tail primers for MYO1, we took advantage of this sequence by making a silent point mutation (CCTTGG to CCATGG) to engineer an NcoI site (Figure 1A
pGFP-MYO1T. The GFP-Myo1p tail fusion was constructed by replacing the NcoI GFP-MYO1 head fragment (3kb MYO1 head) in pGFP-MYO1H-MYO1T with an NcoI GFP fragment generated from a GFP sequence amplified from p573-81X with primers: 5′ XhoI-GFP (CTCGAGATGTCTTTGAGTAAAGGAGAAGAACTTTTCAC) and 3′ NcoI-GFP (CCATGGTTTGTATAGTTCATCCATGCCATG). Correct orientation of GFP was tested using restriction digests. p81-MYO1H-myo2T/-MYO1H-myp2T/-myo2H-MYO1T/-myp2H-MYO1T. Fission yeast MYO1-myo2/myp2 chimera plasmids were constructed using head-tail module replacement (as described for budding yeast pPGT chimera plasmids; see above). p81-myo2H-myp2T and p81-myp2H-myo2T plasmids were linearized appropriately and used to generate the various chimera constructs by religation with appropriate modules. p81-MYO1. A NotI/SalI MYO1 fragment was liberated from pGFP-MYO1 and ligated into NotI/SalI linearized p573-81X. p81-myo2H. A subfragment-1 (S1)-like Myo2Hp-GFP (“S1-like”) head fusion was constructed by inserting a myo2 head fragment into p572-81X. The head (base pairs 1-2445; aa 1-815) was amplified using the primers 5′ NotI-myo2-S1 (GCGGCCGCGGCGGTGGAATGACAGAAGTAATATCTAATAAAATAACTGC) and 3′ NotI-myo2-S1 (GCGGCCGCCGGGCCTTAGATTGAAAAATAACTTAGC). pFA6a-natMX4. This plasmid was generated by replacing the NcoI/SacI kanR fragment from pFA6a-kanMX6 (Bahler et al., 1998 ) with an NcoI/SacI natR fragment derived from pAG36 (Goldstein and McCusker, 1999 ).Database Searches and Sequence Analysis Uncharacterized fungal myosin-II amino acid sequences were identified from various genomes via sequence homology comparisons with the S. pombe Myo2p motor. The following resources were used: Aspergillus fumigatus Genome Project (http://www.tigr.org/tdb/e2k1/afu1/), Munich Information Center for Protein Sequences (http://mips.gsf.de/projects/fungi/neurospora.-html), Candida albicans Research Lab (http://candida.bri.nrc.ca/candida/index.cfm), and Cryptococcus neoformans Genome Project (http://www.tigr.org/tdb/e2k1/cna1/). The probability of coiled-coil conformation within myosin-II tail sequences was calculated by the COILS program (Lupas et al., 1991 ; http://www.ch.embnet.org/software/COILS_form.html) using a window width of 28 amino acids.RESULTS Budding Yeast Myo1p Functions without Its Head Initial studies using myosin-II chimeras (consisting of various combinations of Myo1p, Myo2p, and Myp2p heads and tails) led to a surprising observation. Like full-length GFP-Myo1p, chimeras consisting of either the GFP-Myo2p head or the GFP-Myp2p head fused to the Myo1p tail localized to contractile rings and rescued cytokinesis defects of the budding yeast myo1Δ strain (Figure 1B ; Lord and Pollard, 2004 ). Naturally, Rng3p is not present in budding yeast, and She4p, the only UCS protein common to budding yeast, is specific for type I and V myosins, not type II Myo1p (Toi et al., 2003 ; Wesche et al., 2003 ). To rule out the possibility that She4p was substituting for Rng3p in budding yeast to promote the motor activity of the GFP-Myo2H-Myo1Tp, we tested the ability of this chimera to rescue loss of Myo1p function in a double deletion mutant lacking both MYO1 and SHE4. In the absence of any UCS protein, GFP-Myo2H-Myo1Tp still fully supported Myo1p function (Figure 1, D and E
To test whether the motor domain is required for myosin-II function in budding yeast, we constructed a truncated form of Myo1p consisting of GFP fused to the Myo1p tail. Remarkably, plasmid expression of this headless Myo1p construct (GFP-Myo1Tp) fully restores Myo1p function in a myo1Δ strain (BF264-Du) and concentrates in a ring at the bud neck (Figures (Figures1F1F
The ring of GFP-Myo1Tp in the bud neck constricted during cytokinesis (Figure 2A ). To confirm that the Myo1p tail contractile rings, such as those shown in Figure 2A ), the Myo1p tail formed complete, uninterrupted rings (Figure 2CMyo1p tail alone was also sufficient for function in the W303a strain, where loss of MYO1 is lethal. We transformed the heterozygote myo1Δ/MYO1 diploid with plasmids carrying GFP (vector alone), GFP-Myo1p, or GFP-Myo1Tp. Transformants were sporulated and tetrads dissected to test which of these plasmids rescue the lethality of haploid myo1Δ segregants. The vector alone did not rescue, whereas both GFP-Myo1p and GFP-Myo1Tp constructs rescued myo1Δ lethality as demonstrated by recovery of kanR segregants complemented (Trp+) by pPGT-MYO1 or pPGT-MYO1T (Table 4). Both GFP-Myo1p and GFP-Myo1Tp concentrated in contractile rings at mother-bud necks (Figure 3, A and B
Fission Yeast Myosin-II Function Requires Both Heads and Tails In contrast to budding yeast Myo1p, both the head and tail of fission yeast Myp2p are essential for function. Unlike full-length GFP-Myp2p, tailless (GFP-Myp2Hp) or headless (GFP-Myp2Tp) forms of Myp2p did not support myp2 function (Figure 4, A and B
Previous work established that Myo2p function requires both its catalytic head and tail domains. Point mutations in either the Myo2p head (Naqvi et al., 1999 ) or tail (Mulvihill et al., 2001 ; Motegi et al., 2004 ) can compromise function. Interestingly, a Myo2p Head-GFP fusion localized at contractile rings in wild-type or myo2-E1 cells, despite being unable to substitute functionally for myo2 (Table 3 and Figure 4D ; Table 3) in spite of diffuse accumulation of the Myo2p tail at the medial division site.Table 3 summarizes complementation and localization experiments for myosin-II head or tail truncations and all possible combinations of Myo1p/Myo2p/Myp2p head-tail chimeras. Both the negative and positive results are consistent with previous work (Naqvi et al., 1999 ; Bezanilla and Pollard, 2000 ) and the interpretations made in our present study. We do not emphasize the negative results, because we cannot rule out the possibility that negative complementation/localization results arose from inefficient expression rather than failure to function.DISCUSSION In the contractile ring model of cytokinesis, actin filaments and myosin-II constrict the cleavage furrow. Presumably, the tails of the myosin-II molecules assemble bipolar filaments so that myosin heads can interact with oppositely polarized ring actin filaments in a sliding filament mechanism similar to muscle contraction. However, this and other recent work suggest that the role of myosin-II tails in cytokinesis is more complex. Remarkably, the tail of Myo1p is essential for cytokinesis in budding yeast, but the heads are dispensable. Both the heads and tails of myosin-II are required for cytokinesis in other cells, including fission yeast. Other myosins can fulfill some of their roles in cells with compromised motor activity, but Myo1p is the first example of a myosin that functions in the complete absence of its motor domain. Mutant forms of fission yeast Myo2p possessing only 5% of the wild-type in vitro motility activity (measured by actin filament gliding assays) support normal cytokinesis in vivo (Lord and Pollard, 2004 ). Furthermore, mutant forms of the essential type-I myosin from Aspergillus with only 1% of the wild-type actin-activated ATPase activity still support normal cell growth with only minor phenotypic defects (Liu et al., 2001 ). On the other hand, Dictyostelium myosin-II lacking its ELC binds actin filaments but has <10% of wild-type actin-activated ATPase activity (Chen et al., 1995 ). Cells lacking ELC fail to complete cytokinesis, yet still move reasonably normally (Chen et al., 1995 ; Xu et al., 2001 ; Laevsky and Knecht, 2003 ).Why should the requirements for myosin-II in cytokinesis differ in budding yeast? Two possibilities come to mind. First, contractile force may not be required for cytokinesis in budding yeast. Growth of the septum might conceivably fill in the narrow neck between mother and bud, with the ring of actin filaments growing smaller by disassembly. Alternatively, another myosin, such as Sc Myo2p, may interact with actin filaments to constrict the ring. Budding yeast Myo2p is an essential type-V myosin that localizes to polarized growth sites and the bud neck (Johnston et al., 1991 ; Brockerhoff et al., 1994 ; Lillie and Brown, 1994 ; Govindan et al., 1995 ). Vesicle targeting dependent on Sc Myo2p facilitates septum closure (Wagner et al., 2002 ), which may produce the force to drive ring constriction in the absence of myosin-II motor activity. A role for this type-V myosin in cytokinesis is supported by genetic studies revealing that defects of a myo1Δ and a myo2-66 mutation are additive when combined (Lillie and Brown, 1998 ).Despite lacking a motor domain the Myo1p tail concentrated in the ring structure at the bud neck and constricted with almost wild-type dynamics. Tolliday et al. (2003 ) reported an unpublished observation that a construct consisting of the C-terminal 868 amino acids of Myo1p localizes to the bud neck. However, overexpression of this C-terminal region of Myo1p from the GAL1 promoter was toxic resulting in cells with cytokinesis defects reminiscent of a myo1Δ strain (Tolliday et al., 2003 ). This phenotype presumably stems from complications caused by an overabundance of the Myo1p tail, because we find that expression of the Myo1p tail from its native promoter had no negative effects on cytokinesis.Because the function of budding yeast myosin-II does not depend on its motor domain, its tail must contribute productively to cytokinesis in some way. Myo1p tails might form filaments or interact with septins and/or other structural proteins to stabilize the bud neck during bud out-growth, allowing other mechanisms such as new membrane addition and septum formation to close the narrow orifice. Indeed, ring contraction and primary septum formation are interdependent (Schimdt et al., 2002; VerPlank and Li, 2005 ), suggesting a role for Myo1p in coordinating septation and contractile ring closure. Myosin-II contributes to the mechanical stability of the cortex in Dictyostelium (Pasternak et al., 1989 ), although this is thought to depend on interaction of the heads with actin filaments.Assembly of contractile rings also differs in the two yeast. Budding yeast Myo1p occurs at the division site much earlier in the cell cycle (G1/S) than in other cells. Further Myo1p localization depends on assembly of the septin complex (Bi et al., 1998 ; Lippincott and Li, 1998 ). Fission yeast septins are not essential and occur at the division site later than Myo2p and Myp2p (Wu et al., 2003 ; An et al., 2004 ).Features of the Myo1p Tail That May Support a Novel Role for Myosin-II in Fungal Cytokinesis Available genome sequences show that fungi have two types of myosin-II. Some, including S. pombe Myo2p and Cryptococcus neoformans MyoII, have tails like conventional animal myosin-II, consisting almost entirely a coiled-coil. Most sequenced fungal myosin-II molecules, including S. pombe Myo1p and S. cerevisiae Myp2p, have tails with two distinct regions of predicted coiled-coil separated by a nonhelical insert of 200-270 amino acids (Bezanilla et al., 1997 ; Figure 5 ). Although Myo1p and Myp2p are not functional homologues, the ability of the Myo1p tail to support cytokinesis may arise from an antiparallel coiled-coil structure similar to Myp2p. Given this novel structure, approaches other than simple truncations will be required to determine how the tail of Myo1p functions in cytokinesis without its heads.
Fission Yeast Type-II Myosins Function as Actin-dependent Motors Unlike budding yeast, fission yeast type-II myosins act like other conventional myosins, requiring both their heads and tails for function. Point mutations in either the head or tail of Myo2p can attenuate its function (Balasubramanian et al., 1998 ; Naqvi et al., 1999 ; Wong et al., 2000 ; Motegi et al., 2004 ), whereas truncated forms of Myp2p lacking either the head or tail fail to support Myp2p function. Second, unlike Myo1p, both Myo2p and Myp2p require actin filaments to form a compact contractile ring at anaphase A (Naqvi et al., 1999 ; Wu et al., 2003 ). Third, Myo2p contractile ring localization requires Rng3p, a motor regulator (Wong et al., 2000 ; Lord and Pollard, 2004 ), whereas the Rng3p homolog (She4p) is dispensable for the localization and function of Myo1p (Toi et al., 2003 ; Wesche et al., 2003 ). Fourth, loss of the S. pombe RLC (Rlc1p) results in temperature-sensitive lethality (Le Goff et al., 2000 ; Naqvi et al., 2000 ), whereas loss of the budding yeast RLC (Mlc2p) has only very subtle effects on Myo1p localization and cytokinesis (Luo et al., 2004 ). As in cells possessing headless Myo1p, deletion of MLC2 yields Myo1p contractile rings that disappear slower than in wild-type strains, suggesting a nonessential role for Mlc2p and Myo1p motor activity in ring disassembly (Luo et al., 2004 ). Such subtle effects on contractile ring dynamics suggest that the Myo1p motor may play a secondary, nonessential role in budding yeast cytokinesis. The fact that Myo2p and Myp2p motor activity is essential for myosin-II function represents an advantage for fission yeast in studying cytokinesis powered by conventional myosin-II behavior.Acknowledgments We thank John Chant for budding yeast strains and plasmids. We thank Jian-Qiu Wu for the myp2 promoter plasmid and the GFP-Myp2p strain,Mohan Balasubramanian for the myo2-E1 strain, Rong Li for the myo1Δ heterozygote W303a strain, and Susan Forsburg for numerous fission yeast strains and plasmids. We thank members of the Pollard laboratory for helpful discussions. This work was supported by National Institutes of Health Grant GM-26231 to T.D.P. Notes This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05-07-0601) on September 7, 2005. Abbreviations used: ELC, essential light chain; RLC, regulatory light chain; UCS, Unc-45-/Cro1p-/She4p-related. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Mol Biol Cell. 2000 Jan; 11(1):79-91.
[Mol Biol Cell. 2000]J Cell Biol. 1977 Jul; 74(1):251-63.
[J Cell Biol. 1977]Microbiol Mol Biol Rev. 2002 Jun; 66(2):155-78.
[Microbiol Mol Biol Rev. 2002]Mol Biol Cell. 2002 Jul; 13(7):2448-60.
[Mol Biol Cell. 2002]J Biol. 2003; 2(4):27.
[J Biol. 2003]J Cell Biol. 2003 Sep 15; 162(6):1079-88.
[J Cell Biol. 2003]J Biol Chem. 1981 Dec 25; 256(24):13137-42.
[J Biol Chem. 1981]Curr Opin Cell Biol. 1999 Feb; 11(1):26-33.
[Curr Opin Cell Biol. 1999]J Cell Biol. 2004 Oct 25; 167(2):315-25.
[J Cell Biol. 2004]Mol Biol Cell. 1997 Oct; 8(10):2089-99.
[Mol Biol Cell. 1997]Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13652-7.
[Proc Natl Acad Sci U S A. 1998]J Cell Biol. 1995 Aug; 130(3):651-60.
[J Cell Biol. 1995]J Cell Sci. 2000 May; 113 ( Pt 10)():1813-25.
[J Cell Sci. 2000]Nat Cell Biol. 2000 Nov; 2(11):855-8.
[Nat Cell Biol. 2000]J Cell Biol. 2004 Oct 25; 167(2):315-25.
[J Cell Biol. 2004]J Cell Sci. 2000 Dec; 113 Pt 23():4157-63.
[J Cell Sci. 2000]EMBO J. 1987 Nov; 6(11):3499-505.
[EMBO J. 1987]J Cell Biol. 1998 Sep 7; 142(5):1301-12.
[J Cell Biol. 1998]J Cell Biol. 1998 Jan 26; 140(2):355-66.
[J Cell Biol. 1998]J Cell Sci. 2002 Jan 15; 115(Pt 2):293-302.
[J Cell Sci. 2002]Mol Biol Cell. 2003 Feb; 14(2):798-809.
[Mol Biol Cell. 2003]Methods Enzymol. 1991; 194():795-823.
[Methods Enzymol. 1991]Mol Biol Cell. 2003 Feb; 14(2):798-809.
[Mol Biol Cell. 2003]Yeast. 1998 Jul; 14(10):943-51.
[Yeast. 1998]J Cell Biol. 2004 Oct 25; 167(2):315-25.
[J Cell Biol. 2004]Mol Biol Cell. 2000 Jan; 11(1):79-91.
[Mol Biol Cell. 2000]Yeast. 1998 Jul; 14(10):943-51.
[Yeast. 1998]Yeast. 1999 Oct; 15(14):1541-53.
[Yeast. 1999]Science. 1991 May 24; 252(5010):1162-4.
[Science. 1991]J Cell Sci. 2000 Jul; 113 ( Pt 13)():2421-32.
[J Cell Sci. 2000]J Cell Biol. 2004 Oct 25; 167(2):315-25.
[J Cell Biol. 2004]Mol Biol Cell. 2003 Jun; 14(6):2237-49.
[Mol Biol Cell. 2003]Curr Biol. 2003 Apr 29; 13(9):715-24.
[Curr Biol. 2003]J Cell Biol. 2004 Jun 21; 165(6):843-55.
[J Cell Biol. 2004]J Cell Biol. 1998 Sep 7; 142(5):1301-12.
[J Cell Biol. 1998]EMBO J. 1999 Feb 15; 18(4):854-62.
[EMBO J. 1999]Mol Biol Cell. 2001 Dec; 12(12):4044-53.
[Mol Biol Cell. 2001]J Cell Biol. 2004 Jun 7; 165(5):685-95.
[J Cell Biol. 2004]EMBO J. 1999 Feb 15; 18(4):854-62.
[EMBO J. 1999]Mol Biol Cell. 2000 Jan; 11(1):79-91.
[Mol Biol Cell. 2000]J Cell Biol. 2004 Oct 25; 167(2):315-25.
[J Cell Biol. 2004]Proc Natl Acad Sci U S A. 2001 Jul 31; 98(16):9122-7.
[Proc Natl Acad Sci U S A. 2001]J Cell Sci. 1995 Oct; 108 ( Pt 10)():3207-18.
[J Cell Sci. 1995]Dev Biol. 2001 Apr 1; 232(1):255-64.
[Dev Biol. 2001]J Cell Sci. 2003 Sep 15; 116(Pt 18):3761-70.
[J Cell Sci. 2003]J Cell Biol. 1991 May; 113(3):539-51.
[J Cell Biol. 1991]J Cell Biol. 1994 Feb; 124(3):315-23.
[J Cell Biol. 1994]J Cell Biol. 1994 May; 125(4):825-42.
[J Cell Biol. 1994]J Cell Biol. 1995 Mar; 128(6):1055-68.
[J Cell Biol. 1995]EMBO J. 2002 Dec 2; 21(23):6397-408.
[EMBO J. 2002]Mol Biol Cell. 2003 Feb; 14(2):798-809.
[Mol Biol Cell. 2003]Mol Biol Cell. 2005 May; 16(5):2529-43.
[Mol Biol Cell. 2005]Nature. 1989 Oct 12; 341(6242):549-51.
[Nature. 1989]J Cell Biol. 1998 Sep 7; 142(5):1301-12.
[J Cell Biol. 1998]J Cell Biol. 1998 Jan 26; 140(2):355-66.
[J Cell Biol. 1998]Dev Cell. 2003 Nov; 5(5):723-34.
[Dev Cell. 2003]Mol Biol Cell. 2004 Dec; 15(12):5551-64.
[Mol Biol Cell. 2004]Mol Biol Cell. 1997 Dec; 8(12):2693-705.
[Mol Biol Cell. 1997]Mol Biol Cell. 2000 Jan; 11(1):79-91.
[Mol Biol Cell. 2000]Genetics. 1998 Jul; 149(3):1265-75.
[Genetics. 1998]EMBO J. 1999 Feb 15; 18(4):854-62.
[EMBO J. 1999]J Cell Sci. 2000 Jul; 113 ( Pt 13)():2421-32.
[J Cell Sci. 2000]J Cell Biol. 2004 Jun 7; 165(5):685-95.
[J Cell Biol. 2004]Dev Cell. 2003 Nov; 5(5):723-34.
[Dev Cell. 2003]Mol Biol Cell. 2003 Feb; 14(2):798-809.
[Mol Biol Cell. 2003]Science. 1991 May 24; 252(5010):1162-4.
[Science. 1991]Mol Biol Cell. 2000 Jan; 11(1):79-91.
[Mol Biol Cell. 2000]EMBO J. 1999 Feb 15; 18(4):854-62.
[EMBO J. 1999]